Non-ST Elevation Acute Coronary Syndrome: Aspirin Omission Study

We are investigating if avoiding aspirin can reduce bleeding risks for patients with non-ST segment elevation acute coronary syndrome. The goal is to see if this approach is as effective as current treatments for heart issues.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Acetylsalicylzuur Cardio Aurobindo
Acetylsalicylzuur Cardio Aurobindo is a low-dose aspirin used to help prevent heart attacks and strokes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Acetylsalicylic Acid
Acetylsalicylic acid is a substance that reduces pain, fever, and inflammation and can help prevent blood clots.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aas
Abrea
Acard

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Onze Lieve Vrouw Ziekenhuis
cardiology
Aalst, Belgium
Het Ziekenhuisnetwerk Antwerpen
Cardiology
Berchem, Belgium
CHU Helora
Cardiology
Fayt-lez-Manage, Belgium

Sponsor: Amsterdam UMC
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.